title: Open aortic valve replacement in a patient with Glanzmann's thrombasthenia: a multidisciplinary strategy to minimize perioperative bleeding.
abstract: BACKGROUND
  Glanzmann thrombasthenia (GT) is an autosomal recessive disorder in which the platelet (PLT) glycoprotein IIb/IIIa complex is either deficient or dysfunctional. In its most severe form, GT may result in spontaneous bleeding, although most cases are first detected in the setting of an invasive procedure.
  
  
  METHODS
  A 59-year-old male with Type I GT and a history of transfusion reactions to PLT infusions developed severe aortic stenosis secondary to bicuspid valve disease. He successfully underwent open aortic valve replacement with cardiopulmonary bypass without perioperative bleeding complications.
  
  
  RESULTS
  A multidisciplinary team (anesthesia, hematology, cardiac surgery, and transfusion medicine) was established to optimize perioperative hematologic management. Bleeding risk was assessed given the patient's prior history and a dosing timeline for administration of blood products and recombinant clotting factors was established. Successful management was achieved during the operation by prophylactic administration of HLA-matched PLTs and Factor VIIa. Prophylactic PLT administration was continued through the immediate postoperative period and no bleeding complications occurred. Thromboelastograms (TEGs) were used in conjunction with traditional hematologic laboratory analysis to optimize clinical management.
  
  
  CONCLUSIONS
  Patients with GT requiring cardiac surgical procedures are at high risk for perioperative bleeding complications. This case report illustrates the importance of multidisciplinary planning, TEG analysis, and the judicious use of recombinant factors to minimize operative bleeding risk.
authors.affiliation: Departments of Cardiac Surgery, Anesthesiology, Pathology, and Medicine, Stanford University, Stanford, California.
authors.forename: Ahmad Y
authors.initials: AY
authors.lastname: Sheikh
authors.forename: Charles C
authors.initials: CC
authors.lastname: Hill
authors.forename: Lawrence T
authors.initials: LT
authors.lastname: Goodnough
authors.forename: Lawrence L
authors.initials: LL
authors.lastname: Leung
authors.forename: Michael P
authors.initials: MP
authors.lastname: Fischbein
mesh_terms: D001024:Aortic Valve Stenosis / Q000150:complications* / Q000601:surgery*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D010348:Patient Care Team; D059035:Perioperative Period; D013915:Thrombasthenia / Q000097:blood / Q000150:complications*; D016896:Treatment Outcome